spacer
home > ebr > spring 2002 > certain aspects related to shareholders' agreements in biotech companies
PUBLICATIONS
European Biopharmaceutical Review

Certain Aspects Related to Shareholders' Agreements in Biotech Companies

A biotechnology company and its management have many challenges to face these days. Research projects and the business of the company should constantly progress, but at the same time research-oriented companies need to have balanced finance for expensive research projects. It is often the case that when one financing round is completed the management has to begin planning the next. Private equity investments as well as public subsidies are often the only finance available to start-up biotechnology companies. Loans and credits from banks or other financial institutions are often too expensive sources of financing for these companies. Moreover, start-up biotechs rarely possess the necessary assets to be used as security for the bank's financing. In such cases, venture capital finance plays an important role for biotech companies.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Ben Rapinoja, Attorney at Borenius & Kemppinen Ltd

Ben Rapinoja's areas of expertise are intellectual property rights (IPR) - in particular patents, trademarks and contract law. His legal practise relates to the licensing and commercial exploitation of IPR, as well as litigation within patent, trademark and copyright law. Ben advises expanding companies in the biotechnology and pharmaceutical sectors in matters related to corporate law and contracts. He also advises companies with interests in the information technology sector.
Before joining Borenius & Kemppinen, Ben worked at the Ministry of Trade and Industry, gaining experience in IPR law. He was also a Finnish Government representative working with various groups of the European Union Council and Commission, the European Patent Organisation and international organisations specialising in IPR (such as WIPO and WTO).

spacer
Ben Rapinoja
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Organization Updates

Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following management updates to help drive the company’s future vision, strategy and growth.
More info >>

White Papers

Device Develop for Combo Products

Phillips-Medisize

Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>

 
Industry Events

World Vaccine Congress Europe

28-31 October 2019, Barcelona, Spain

The 20th annual World Vaccine Congress Europe is taking place 28-31 Oct in Barcelona. It’s the biggest and most established European vaccine event with over 250 speakers, 700+ senior vaccine attendees, hundreds of networking hours. It cover key topics across the complete vaccine value chain bringing together: • Government • big pharma • big biotech • SME Biotech • academia and the wider service provider community and their partners to discuss scientific, clinical and strategic advances and opportunities. The event has already confirmed over 200 speakers from Human Vaccine Project, OECD, CEPI, European Commission, FDA, WHO, OECD, NIH, GSK and many more… There is a Super Early Bird offer available – Find Out More www.terrapinn.com/WVCEU/EBR
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement